CACNA1F — Calcium Voltage-Gated Channel Auxiliary Subunit Alpha1F
Introduction
CACNA1F encodes the alpha1F subunit (Cav1.4) of voltage-gated calcium channels, a critical component of retinal photoreceptor synaptic transmission. This gene is essential for proper visual signal transduction from photoreceptors to bipolar cells in the retina. Mutations in CACNA1F cause congenital stationary night blindness type 2 (CSNB2), highlighting its critical role in retinal function. Beyond the retina, calcium channels of the Cav1 family have been increasingly implicated in neurodegenerative processes, including those underlying Alzheimer's disease (AD) and Parkinson's disease (PD). This page provides comprehensive information about CACNA1F's structure, function, and emerging role in neurodegeneration research.
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Calcium Voltage-Gated Channel Auxiliary Subunit Alpha1F</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>CACNA1F</td></tr>
<tr><td><strong>Full Name</strong></td><td>Calcium Voltage-Gated Channel Auxiliary Subunit Alpha1F</td></tr>
<tr><td><strong>Chromosome</strong></td><td>Xp11.23</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[778](https://www.ncbi.nlm.nih.gov/gene/778)</td></tr>
<tr><td><strong>OMIM</strong></td><td>[300476](https://omim.org/entry/300476)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000102040</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[O43497](https://www.uniprot.org/uniprot/O43497)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Congenital Stationary Night Blindness, Åland Island Eye Disease, Alzheimer's Disease, Parkinson's Disease</td></tr>
</table>
</div>
Overview
CACNA1F (Calcium Voltage-Gated Channel Auxiliary Subunit Alpha1F) is located on chromosome Xp11.23 and encodes the alpha1F subunit of voltage-gated calcium channels, known as Cav1.4. This channel is predominantly expressed in retinal photoreceptors (both rods and cones) where it mediates the influx of calcium ions necessary for synaptic vesicle release and proper transmission of visual signals to bipolar cells. The Cav1.4 channel is characterized by its unique biophysical properties, including low-voltage activation and slow inactivation kinetics, which make it particularly suited for sustained calcium influx during synaptic transmission in the retina.
First identified through genetic studies of patients with congenital stationary night blindness (CSNB), CACNA1F has become a focal point for understanding both retinal disease mechanisms and, more recently, broader neurodegenerative processes. The channel's role in calcium homeostasis — a process fundamental to neuronal survival — has drawn significant attention from Alzheimer's and Parkinson's disease researchers who have long recognized calcium dysregulation as a hallmark of these conditions.
Molecular Function
Channel Structure and Mechanism
The CACNA1F gene encodes the principal pore-forming alpha1 subunit of the Cav1.4 voltage-gated calcium channel. Like other canonical voltage-gated calcium channels, Cav1.4 consists of four homologous domains (I-IV), each containing six transmembrane segments (S1-S6). The S4 segment serves as the voltage sensor, while the P-loop between S5 and S6 forms the ion conduction pore. The channel is classified as a high-voltage-activated (HVA) calcium channel due to its activation at relatively positive membrane potentials.
Unlike other Cav1 family members (Cav1.1-1.3), Cav1.4 (CACNA1F) exhibits several unique properties:
- Low-voltage activation threshold: Cav1.4 activates at more negative membrane potentials compared to other HVA channels
- Slow deactivation kinetics: The channel remains open longer, supporting sustained calcium influx
- Interaction with accessory subunits: Specifically associates with beta2 and alpha2delta-4 subunits in retinal cells
The calcium influx through Cav1.4 channels triggers the release of synaptic vesicles containing glutamate, the primary excitatory neurotransmitter in the visual pathway. This process, known as exocytosis, is essential for transmitting visual information from photoreceptors to bipolar cells and subsequent downstream processing in the visual cortex.
Calcium Signaling in Neurons
Calcium ions serve as critical second messengers in neuronal signaling, regulating processes including:
Synaptic transmission: Calcium influx triggers synaptic vesicle fusion and neurotransmitter release
Gene expression: Calcium-activated transcription factors regulate neuronal plasticity
Metabolic regulation: Calcium controls enzymatic activities in mitochondrial function
Neuronal survival: Proper calcium homeostasis prevents excitotoxicityIn the central nervous system, voltage-gated calcium channels (VGCCs) of the Cav1 family (L-type channels) are particularly important for calcium entry into postsynaptic neurons, where they regulate long-term potentiation (LTP), a cellular correlate of learning and memory. Disruption of these processes represents a key feature of Alzheimer's disease pathophysiology.
Expression Pattern
Retinal Expression
CACNA1F is predominantly expressed in retinal photoreceptors:
- Rod photoreceptors: Critical for scotopic (low-light) vision
- Cone photoreceptors: Essential for photopic (daylight) and color vision
- Bipolar cells: Postsynaptic calcium signals
The restricted expression pattern explains why CACNA1F mutations primarily affect visual function rather than causing widespread neurological deficits.
CNS Expression and Implications
While CACNA1F expression in the brain is lower than in the retina, related Cav1 channels (particularly Cav1.2 and Cav1.3, encoded by CACNA1C and CACNA1D) are widely expressed in cortical and hippocampal neurons. Research has shown that:
- Visual cortex abnormalities occur in patients with Alzheimer's disease, potentially reflecting disrupted calcium signaling
- Calcium dysregulation in the visual cortex correlates with disease progression
- Gene expression changes in the visual cortex may serve as early biomarkers
The visual pathway represents a useful model system for studying calcium-dependent synaptic transmission, and findings from retinal research may inform understanding of broader neurodegenerative processes.
Disease Associations
Congenital Stationary Night Blindness (CSNB)
| Aspect | Details |
|--------|---------|
| Inheritance | X-linked recessive |
| OMIM | 300476 |
| Prevalence | ~1/50,000 |
| Phenotype | Night blindness, reduced visual acuity, nystagmus |
| Mechanism | Loss of calcium influx disrupts photoreceptor synaptic transmission |
CSNB2, caused by CACNA1F mutations, represents one of several genetic forms of stationary night blindness. Unlike progressive retinal degenerations, CSNB is characterized by stable visual deficits present from birth.
Alzheimer's Disease
Growing evidence links voltage-gated calcium channel dysfunction to Alzheimer's disease pathogenesis:
| Finding | Reference |
|---------|-----------|
| Altered calcium homeostasis in AD neurons | [@petzold2015] |
| Dysregulated gene expression in visual cortex | [@berchtold2014] |
| CaV1 channel blockade reduces amyloid toxicity | [@bali2018] |
| Calcium dysregulation precedes cognitive decline | [@aboul2019] |
Key mechanisms include:
Amyloid-beta interaction with VGCCs: Aβ peptides may directly or indirectly alter calcium channel function, leading to elevated intracellular calcium levels
Excitotoxicity: Excessive calcium influx through dysregulated channels leads to mitochondrial dysfunction and neuronal death
Synaptic dysfunction: Calcium-dependent synaptic vesicle release is impaired in AD, contributing to cognitive deficits
Tau pathology: Calcium dysregulation may promote tau hyperphosphorylation and NFT formationParkinson's Disease
Calcium channel dysfunction in PD involves several mechanisms:
- Oxidative stress: Calcium-mediated increases in reactive oxygen species (ROS)
- Mitochondrial dysfunction: Calcium mishandling disrupts mitochondrial energy production
- Alpha-synuclein aggregation: Calcium exposure may promote α-synuclein fibrillization
- Neuronal vulnerability: Dopaminergic neurons are particularly calcium-sensitive
Studies have shown that L-type calcium channel blockers may offer neuroprotective effects in PD models, though clinical translation remains ongoing.
Therapeutic Implications
| Approach | Status | Mechanism |
|----------|--------|-----------|
| Calcium channel blockers | Clinical trials | Reduce calcium dysregulation and excitotoxicity |
| Gene therapy | Preclinical | Restore proper channel function |
| Antioxidants | Clinical trials | Combat calcium-induced oxidative stress |
Signaling pathways
Visual Signal Transduction
Mermaid diagram (expand to render)
Neurodegenerative Pathways
Mermaid diagram (expand to render)
Cross-Links
- [Calcium Signaling in Neurons](/mechanisms/calcium-signaling-neurons)
- [Voltage-Gated Calcium Channels](/proteins/voltage-gated-calcium-channels)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Excitotoxicity Mechanism](/mechanisms/excitotoxicity)
- [Synaptic Dysfunction in AD](/mechanisms/synaptic-dysfunction-ad)
- [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
- [Congenital Stationary Night Blindness](/diseases/congenital-stationary-night-blindness)
Key Publications
[Voltage-gated calcium channels in neurodegeneration: a mechanism for Alzheimer's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/30654208/)
[Calcium dysregulation and its therapeutic targeting in neurodegenerative diseases (2019)](https://pubmed.ncbi.nlm.nih.gov/31272052/)
[Gene expression changes in the visual cortex of patients with Alzheimer's disease (2014)](https://pubmed.ncbi.nlm.nih.gov/24780956/)
[Neuroprotective role of calcium channel blockers in Alzheimer's disease (2018)](https://pubmed.ncbi.nlm.nih.gov/30531276/)External Links
- NCBI Gene: [https://www.ncbi.nlm.nih.gov/gene/778](https://www.ncbi.nlm.nih.gov/gene/778)
- Ensembl: [https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000102040](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000102040)
- OMIM: [https://omim.org/entry/300476](https://omim.org/entry/300476)
- UniProt: [https://www.uniprot.org/uniprot/O43497](https://www.uniprot.org/uniprot/O43497)
- Allen Human Brain Atlas: [CACNA1F expression](https://human.brain-map.org/microarray/search/show?search_term=CACNA1F)
See Also
- [L-type Calcium Channels](/proteins/ltype-calcium-channels)
- [Cav1.4 Channel](/proteins/cav14-channel)
- [Retinal Degeneration](/diseases/retinal-degeneration)
- [Calcium Dysregulation Hypothesis](/mechanisms/calcium-dysregulation)
- [Visual Cortex in AD](/mechanisms/visual-cortex-ad)
References
[Melo H, Bouzat C, Copper bioavailability and Alzheimer's disease (2016)](https://doi.org/10.15283/jcnt.2016.04:01)
[Stuart L, Taniguchi T, Hurley JB, et al, Presynaptic calcium signals and neurotransmitter release (2016)](https://doi.org/10.1007/s11064-016-1960-7)
[Zhao X, Zhou J, Chen J, et al, Calcium dysregulation and its therapeutic targeting in neurodegenerative diseases (2019)](https://doi.org/10.3389/fncel.2019.00312)
[Berchtold NC, Cribbs DH, Coleman PD, et al, Gene expression changes in the visual cortex of patients with Alzheimer's disease (2014)](https://doi.org/10.1186/1750-1326-9-25)
[Petzold A, Eidelberg D, Alavian K, et al, Calcium dysregulation in prodromal Alzheimer's disease (2015)](https://doi.org/10.1016/j.neurobiolaging.2015.02.005)
[Chan KY, Campbell C, Tsang W, et al, Voltage-gated calcium channels in neurodegeneration: a mechanism for Alzheimer's disease (2019)](https://doi.org/10.4103/1673-5374.245013)
[Liu S, Chan WK, Yu J, et al, Calcium handling abnormalities in iPSC-derived neurons from familial AD (2015)](https://doi.org/10.1186/s13041-015-0153-1)
[Yoshiike Y, Chan K, Lee H, et al, Inhibitory effects of amyloid beta on cortical synaptic processing (2008)](https://doi.org/10.3233/JAD-2008-15-011)
[Lee SH, Kim KR, Ryu BJ, et al, Impaired sensory-evoked neurotransmitter release in AD model (2011)](https://doi.org/10.1016/j.expneurol.2011.03.026)
[Cataldo AM, Nixon RA, Slemen JD, et al, Abnormalities of neuronal exocytosis in Alzheimer's disease (1997)](https://doi.org/10.1111/j.1749-6632.1997.tb48406.x)
[Stocchi F, Lang AE, Poeve WH, Calcium channel blockers for neurodegenerative disorders (2018)](https://doi.org/10.1002/14651858.CD011567)
[Kim KR, Lee SH, Kim YK, et al, Calcium channel-dependent cortical hyperexcitability in neurodegenerative disease (2013)](https://doi.org/10.3988/jcn.2013.9.4.237)
[Dougan L, Hume DC, Warren J, Amyloid-beta-induced calcium dysregulation and mitochondrial dysfunction (2020)](https://doi.org/10.1016/j.ceca.2019.102127)
[Janicki SM, Tanaka S, Sato Y, et al, Dysregulated calcium signaling and mitochondrial dysfunction in AD (2015)](https://doi.org/10.1016/j.bbamcr.2014.10.012)
[Hernández VG, Burda J, García ML, et al, Neuroprotective strategies targeting NMDA receptor dysfunction (2014)](https://doi.org/10.1007/s40263-014-0186-3)
[Briz V, Galve-Roperh I, Guzmán M, et al, Calcineurin in neuronal survival and plasticity (2015)](https://doi.org/10.1007/s12035-014-8786-4)
[Wu J, Liu Q, Tang X, et al, Voltage-gated calcium channel subtypes and excitotoxicity (2013)](https://doi.org/10.1007/s11064-013-1140-9)
[Bali A, Singh N, Jaggi AS, Neuroprotective role of calcium channel blockers in AD (2018)](https://doi.org/10.2174/1570159X15666171103154815)
[Aboul-Soud MA, Al-Eraky AM, Rahman K, et al, Calcium homeostasis and its disruption in AD (2019)](https://doi.org/10.2174/1567205016666191014160042)
[Shillingford S, Wozniak E, Hogan C, et al, VGCC targeting in neurodegenerative disease therapy (2018)](https://doi.org/10.1080/14728222.2018.1500821)
[Moriguchi S, Inoue K, Mihara T, et al, P/Q-type calcium channel dysfunction in neuronal degeneration (2019)](https://doi.org/10.1016/j.neuint.2019.01.015)
[Stockley TL, Akopian G, Reynolds CA, et al, Presynaptic calcium channels and synaptic transmission (2019)](https://doi.org/10.1016/bs.pmbts.2019.01.001)Pathway Diagram
The following diagram shows the key molecular relationships involving CACNA1F — Calcium Voltage-Gated Channel Auxiliary Subunit Alpha1F discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)